Copper-mediated radiosynthesis of [18F]rucaparib
<p>The poly(ADP-ribose) polymerase (PARP) inhibitor rucaparib is used in the clinic to treat <em>BRCA</em>-mutated cancers. Herein, we report two strategies to access the <sup>18</sup>F-isotopologue of rucaparib by applying a copper-mediated nucleophil...
Main Authors: | Chen, Z, Destro, G, Guibbal, F, Chan, CY, Cornelissen, B, Gouverneur, V |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
American Chemical Society
2021
|
Registos relacionados
-
Manual and automated Cu-mediated radiosynthesis of the PARP inhibitor [18F]olaparib
Por: Guibbal, F, et al.
Publicado em: (2020) -
Convergent 18F Radiosynthesis
Por: Gouverneur, V, et al.
Publicado em: (2012) -
Radiosynthesis of [18F]ArylSCF2H using aryl boronic acids, S-(chlorofluoromethyl)benzenesulfonothioate and [18F]fluoride
Por: Zhao, Q, et al.
Publicado em: (2020) -
Copper-mediated radiosynthesis of 18F- and 123I-radiolabelled PARP inhibitors
Por: Chen, Z
Publicado em: (2022) -
Optimizing the radiosynthesis of 6-[F-18]FDOPA using [F-18]Selectfluor
Por: Forsback, S, et al.
Publicado em: (2013)